Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
暂无分享，去创建一个
H. Parving | C. Stehouwer | C. Schalkwijk | P. Rossing | F. Boomsma | F. Persson | C. Schalkwijk | H. Reinhard | A. Danser | T. Juhl | E. Frandsen | C. Stehouwer | T. Juhl | F. Boomsma